328 related articles for article (PubMed ID: 19199380)
21. Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion.
Fromigué O; Hamidouche Z; Marie PJ
J Biol Chem; 2008 Nov; 283(45):30549-56. PubMed ID: 18757369
[TBL] [Abstract][Full Text] [Related]
22. Activation of the FAK-src molecular scaffolds and p130Cas-JNK signaling cascades by alpha1-integrins during colon cancer cell invasion.
Van Slambrouck S; Grijelmo C; De Wever O; Bruyneel E; Emami S; Gespach C; Steelant WF
Int J Oncol; 2007 Dec; 31(6):1501-8. PubMed ID: 17982677
[TBL] [Abstract][Full Text] [Related]
23. Low-density lipoprotein receptor-related protein 1 promotes cancer cell migration and invasion by inducing the expression of matrix metalloproteinases 2 and 9.
Song H; Li Y; Lee J; Schwartz AL; Bu G
Cancer Res; 2009 Feb; 69(3):879-86. PubMed ID: 19176371
[TBL] [Abstract][Full Text] [Related]
24. Caveolin-1 regulating the invasion and expression of matrix metalloproteinase (MMPs) in pancreatic carcinoma cells.
Han F; Zhu HG
J Surg Res; 2010 Mar; 159(1):443-50. PubMed ID: 20031158
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of PEAK1 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer through modulating ERK1/2 and JAK2 signaling.
Ding C; Tang W; Fan X; Wang X; Wu H; Xu H; Xu W; Gao W; Wu G
Cell Death Dis; 2018 Jul; 9(8):802. PubMed ID: 30038287
[TBL] [Abstract][Full Text] [Related]
26. Amphiregulin promotes trophoblast invasion and increases MMP9/TIMP1 ratio through ERK1/2 and Akt signal pathways.
Yu Y; Fang L; Wang S; Li Y; Guo Y; Sun YP
Life Sci; 2019 Nov; 236():116899. PubMed ID: 31614145
[TBL] [Abstract][Full Text] [Related]
27. PRL-1 protein promotes ERK1/2 and RhoA protein activation through a non-canonical interaction with the Src homology 3 domain of p115 Rho GTPase-activating protein.
Bai Y; Luo Y; Liu S; Zhang L; Shen K; Dong Y; Walls CD; Quilliam LA; Wells CD; Cao Y; Zhang ZY
J Biol Chem; 2011 Dec; 286(49):42316-42324. PubMed ID: 22009749
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Src activation with cardiotoxin III blocks migration and invasion of MDA-MB-231 cells.
Tsai PC; Chu CL; Chiu CC; Chang LS; Lin SR
Toxicon; 2013 Nov; 74():56-67. PubMed ID: 23933586
[TBL] [Abstract][Full Text] [Related]
29. Increased expression of matrix metalloproteinases mediates thromboxane A2-induced invasion in lung cancer cells.
Li X; Tai HH
Curr Cancer Drug Targets; 2012 Jul; 12(6):703-15. PubMed ID: 22515524
[TBL] [Abstract][Full Text] [Related]
30. CT45A1 siRNA silencing suppresses the proliferation, metastasis and invasion of lung cancer cells by downregulating the ERK/CREB signaling pathway.
Tang F; Tang S; Guo X; Yang C; Jia K
Mol Med Rep; 2017 Nov; 16(5):6708-6714. PubMed ID: 28901509
[TBL] [Abstract][Full Text] [Related]
31. IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta , NF-kappaB, and AP-1 activation.
Cortez DM; Feldman MD; Mummidi S; Valente AJ; Steffensen B; Vincenti M; Barnes JL; Chandrasekar B
Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3356-65. PubMed ID: 17921324
[TBL] [Abstract][Full Text] [Related]
32. Timosaponin AIII inhibits migration and invasion of A549 human non-small-cell lung cancer cells via attenuations of MMP-2 and MMP-9 by inhibitions of ERK1/2, Src/FAK and β-catenin signaling pathways.
Jung O; Lee J; Lee YJ; Yun JM; Son YJ; Cho JY; Ryou C; Lee SY
Bioorg Med Chem Lett; 2016 Aug; 26(16):3963-7. PubMed ID: 27422337
[TBL] [Abstract][Full Text] [Related]
33. Src tyrosine kinase inhibitor PP2 suppresses ERK1/2 activation and epidermal growth factor receptor transactivation by X-irradiation.
Li Z; Hosoi Y; Cai K; Tanno Y; Matsumoto Y; Enomoto A; Morita A; Nakagawa K; Miyagawa K
Biochem Biophys Res Commun; 2006 Mar; 341(2):363-8. PubMed ID: 16414009
[TBL] [Abstract][Full Text] [Related]
34. PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation.
Liang F; Liang J; Wang WQ; Sun JP; Udho E; Zhang ZY
J Biol Chem; 2007 Feb; 282(8):5413-9. PubMed ID: 17192274
[TBL] [Abstract][Full Text] [Related]
35. JNK1 differentially regulates osteopontin-induced nuclear factor-inducing kinase/MEKK1-dependent activating protein-1-mediated promatrix metalloproteinase-9 activation.
Rangaswami H; Bulbule A; Kundu GC
J Biol Chem; 2005 May; 280(19):19381-92. PubMed ID: 15757900
[TBL] [Abstract][Full Text] [Related]
36. Epidermal growth factor (EGF) and interleukin (IL)-1β synergistically promote ERK1/2-mediated invasive breast ductal cancer cell migration and invasion.
Ma L; Lan F; Zheng Z; Xie F; Wang L; Liu W; Han J; Zheng F; Xie Y; Huang Q
Mol Cancer; 2012 Oct; 11():79. PubMed ID: 23083134
[TBL] [Abstract][Full Text] [Related]
37. EFEMP1 inhibits migration of hepatocellular carcinoma by regulating MMP2 and MMP9 via ERK1/2 activity.
Dou CY; Cao CJ; Wang Z; Zhang RH; Huang LL; Lian JY; Xie WL; Wang LT
Oncol Rep; 2016 Jun; 35(6):3489-95. PubMed ID: 27108677
[TBL] [Abstract][Full Text] [Related]
38. ERK1/2-driven and MKP-mediated inhibition of EGF-induced ERK5 signaling in human proximal tubular cells.
Sarközi R; Miller B; Pollack V; Feifel E; Mayer G; Sorokin A; Schramek H
J Cell Physiol; 2007 Apr; 211(1):88-100. PubMed ID: 17131384
[TBL] [Abstract][Full Text] [Related]
39. The lncRNA TP73-AS1 promotes ovarian cancer cell proliferation and metastasis via modulation of MMP2 and MMP9.
Wang X; Yang B; She Y; Ye Y
J Cell Biochem; 2018 Sep; 119(9):7790-7799. PubMed ID: 29904939
[TBL] [Abstract][Full Text] [Related]
40. Complement regulatory protein CD46 promotes bladder cancer metastasis through activation of MMP9.
Thi TN; Thanh HD; Nguyen VT; Kwon SY; Moon C; Hwang EC; Jung C
Int J Oncol; 2024 Jul; 65(1):. PubMed ID: 38847230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
